Law Offices of Thomas J. Lamb

  • About Firm
  • Practice Areas
  • Free Case Evaluation
  • Quick Contact Form
  • Frequently Asked Questions
  • Attorney Tom Lamb

Syfovre’s Side Effects Keep It Off The Market In Europe (CHMP June 2024)

July 2, 2024 By Law Offices of Thomas J. Lamb, P.A.

As we have been reporting since July 2023, Syfovre’s side effects include occlusive retinal vasculitis, a type of eye inflammation that blocks blood flow to the retina resulting in vision loss and potentially causing blindness. There have also been cases of non-occlusive retinal vasculitis and other types of eye inflammation. In late June 2024, … [Read more...]

Filed Under: Unsafe Drugs Tagged With: occlusive retinal vasculitis, retinal vascular occlusion, retinal vasculitis, Syfovre

New Syfovre Warnings for Retinal Vascular Occlusion and Retinal Vasculitis

December 27, 2023 By Law Offices of Thomas J. Lamb, P.A.

A November 2023 label change added new Syfovre warnings for retinal vascular occlusion and retinal vasculitis cases associated with Syfovre injections. With these new Syfovre warnings, it now seems that the retinal vascular occlusion and retinal vasculitis cases associated with Syfovre use are due to the drug itself and not the injection kits, as … [Read more...]

Filed Under: Unsafe Drugs Tagged With: drug injury lawsuits, retinal vascular occlusion, retinal vasculitis, Syfovre

Beovu Label Change: Novartis Adds Information, Increases Safety Warnings in February 2022

February 25, 2022 By Law Offices of Thomas J. Lamb, P.A.

We had been watching for a second Beovu label change since May 2021, when Novartis stopped three Beovu clinical trials for safety reasons, and, at the same time, said it would update the Beovu drug label. Finally, in February 2022, Novartis added information and increased safety warnings about various Beovu eye-related side effects, such as retinal … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, retinal vascular occlusion, retinal vasculitis, vision loss

Beovu Drug Label Revised December 2021 Was Issued in Europe, But Not in the US

January 22, 2022 By Law Offices of Thomas J. Lamb, P.A.

A “new” Beovu drug label which was revised in December 2021 sets forth some additional information about the vision-related Beovu side effects intraocular inflammation, retinal vasculitis, and retinal vascular occlusion. We point out, however, that there was no similar 2021 Beovu label change issued by Novartis in the US. From this Drug Safety … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, intraocular inflammation, occlusive retinal vasculitis, retinal vascular occlusion, retinal vasculitis, vision loss

Beovu: Rates of Intraocular Inflammation and Retinal Vascular Occlusion

December 22, 2021 By Law Offices of Thomas J. Lamb, P.A.

A November 2021 article published by the medical journal JAMA Ophthalmology, “Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration”, provides new information about the incidence rates of intraocular inflammation and retinal vascular occlusion associated with Beovu (brolucizumab). This is our 19th article about Beovu … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, intraocular inflammation, retinal vascular occlusion, vision loss

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

DrugInjuryLaw.com

DrugInjuryWatch.com

Asbestos-Mesothelioma.com

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Disclaimer and Copyright Notices
  • Sitemap

Copyright © 2025 · Law Offices of Thomas J. Lamb, P.A.